• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子配体增强 siRNA 脂质纳米粒制剂的细胞内递送。

Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA.

机构信息

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Nanomedicine. 2013 Jul;9(5):665-74. doi: 10.1016/j.nano.2012.11.006. Epub 2012 Dec 6.

DOI:10.1016/j.nano.2012.11.006
PMID:23219877
Abstract

UNLABELLED

Gene silencing activity of lipid nanoparticle (LNP) formulations of siRNA requires LNP surface factors promoting cellular uptake. This study aimed to identify small molecules that enhance cellular uptake of LNP siRNA systems, then use them as LNP-associated ligands to improve gene silencing potency. Screening the Canadian Chemical Biology Network molecules for effects on LNP uptake into HeLa cells found that cardiac glycosides like ouabain and strophanthidin caused the highest uptake. Cardiac glycosides stimulate endocytosis on binding to plasma membrane Na(+)/K(+) ATPase found in all mammalian cells, offering the potential to stimulate LNP uptake into various cell types. A PEG-lipid containing strophanthidin at the end of PEG (STR-PEG-lipid) was synthesized and incorporated into LNP. Compared to non-liganded systems, STR-PEG-lipid enhanced LNP uptake in various cell types. Furthermore, this enhanced uptake improved marker gene silencing in vitro. Addition of STR-PEG-lipid to LNP siRNA may have general utility for enhancing gene silencing potency.

FROM THE CLINICAL EDITOR

In this study, the authors identified small molecules that enhance cellular uptake of lipid nanoparticle siRNA systems, then used them as LNP-associated ligands to improve gene silencing potency.

摘要

未加标签

脂质纳米颗粒(LNP)siRNA 制剂的基因沉默活性需要促进细胞摄取的 LNP 表面因素。本研究旨在鉴定能增强 LNP 摄取 siRNA 系统的小分子,然后将它们用作 LNP 相关配体来提高基因沉默效力。筛选加拿大化学生物学网络分子对 HeLa 细胞摄取 LNP 的影响,发现哇巴因和哇巴拉丁等强心苷能引起最高摄取。强心苷与所有哺乳动物细胞中存在的质膜 Na(+) / K(+) ATP 酶结合后会刺激内吞作用,这为刺激各种细胞类型摄取 LNP 提供了潜力。合成了一种在 PEG 末端含有哇巴拉丁的 PEG-脂质(STR-PEG-脂质),并将其掺入 LNP 中。与非配体系统相比,STR-PEG-脂质增强了各种细胞类型中 LNP 的摄取。此外,这种增强的摄取提高了体外标记基因的沉默。将 STR-PEG-脂质添加到 LNP siRNA 中可能对增强基因沉默效力具有普遍适用性。

从临床编辑

在这项研究中,作者鉴定了能增强脂质纳米颗粒 siRNA 系统摄取的小分子,然后将它们用作 LNP 相关配体来提高基因沉默效力。

相似文献

1
Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA.小分子配体增强 siRNA 脂质纳米粒制剂的细胞内递送。
Nanomedicine. 2013 Jul;9(5):665-74. doi: 10.1016/j.nano.2012.11.006. Epub 2012 Dec 6.
2
Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.皮下给药后用于肝细胞基因沉默的 siRNA 的脂质纳米粒制剂的开发。
J Control Release. 2014 Dec 28;196:106-12. doi: 10.1016/j.jconrel.2014.09.025. Epub 2014 Oct 5.
3
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.粒径对 siRNA 脂质纳米粒制剂体内效力的影响。
J Control Release. 2016 Aug 10;235:236-244. doi: 10.1016/j.jconrel.2016.05.059. Epub 2016 May 26.
4
Improved Stability of siRNA-Loaded Lipid Nanoparticles Prepared with a PEG-Monoacyl Fatty Acid Facilitates Ligand-Mediated siRNA Delivery.用聚乙二醇单酯脂肪酸制备的负载 siRNA 的脂质纳米粒稳定性提高,有助于配体介导的 siRNA 递释。
Mol Pharm. 2020 Apr 6;17(4):1397-1404. doi: 10.1021/acs.molpharmaceut.0c00087. Epub 2020 Mar 2.
5
Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA.阳离子脂质组成对 siRNA 脂质纳米粒制剂摄取和细胞内处理的影响。
Nanomedicine. 2013 Feb;9(2):233-46. doi: 10.1016/j.nano.2012.05.019. Epub 2012 Jun 12.
6
The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA.尼曼-皮克C1抑制剂NP3.47增强了含小干扰RNA的脂质纳米颗粒的基因沉默效力。
Mol Ther. 2016 Dec;24(12):2100-2108. doi: 10.1038/mt.2016.179. Epub 2016 Sep 16.
7
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.阳离子脂质组成对抗原呈递细胞中 siRNA 的脂质纳米粒制剂基因沉默特性的影响。
Mol Ther. 2011 Dec;19(12):2186-200. doi: 10.1038/mt.2011.190. Epub 2011 Oct 4.
8
Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.可充电脂质衍生物:一种新型 pH 响应脂质,用于纳米颗粒介导的 siRNA 递药。
Int J Pharm. 2020 Jul 30;585:119479. doi: 10.1016/j.ijpharm.2020.119479. Epub 2020 May 27.
9
Lipid nanoparticles for short interfering RNA delivery.用于短干扰RNA递送的脂质纳米颗粒。
Adv Genet. 2014;88:71-110. doi: 10.1016/B978-0-12-800148-6.00004-3.
10
On the role of helper lipids in lipid nanoparticle formulations of siRNA.关于辅助脂质在 siRNA 脂质纳米粒制剂中的作用。
Nanoscale. 2019 Nov 21;11(45):21733-21739. doi: 10.1039/c9nr09347h.

引用本文的文献

1
Rational design of lipid nanoparticles for enabling gene therapies.用于实现基因治疗的脂质纳米颗粒的合理设计。
Mol Ther Methods Clin Dev. 2025 Jun 18;33(3):101518. doi: 10.1016/j.omtm.2025.101518. eCollection 2025 Sep 11.
2
Biomimetic Exosomes: A New Generation of Drug Delivery System.仿生外泌体:新一代药物递送系统
Front Bioeng Biotechnol. 2022 May 23;10:865682. doi: 10.3389/fbioe.2022.865682. eCollection 2022.
3
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.基于脂质纳米颗粒的CRISPR/Cas9基因组编辑组件递送
Mol Pharm. 2022 Jun 6;19(6):1669-1686. doi: 10.1021/acs.molpharmaceut.1c00916. Epub 2022 May 20.
4
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics.用于实现基于mRNA的治疗药物的脂质纳米颗粒递送系统。
Pharmaceutics. 2022 Feb 11;14(2):398. doi: 10.3390/pharmaceutics14020398.
5
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice.表达恶性疟原虫环子孢子蛋白的信使核糖核酸可诱导小鼠产生针对疟疾的功能性保护性免疫反应。
NPJ Vaccines. 2021 Jun 18;6(1):84. doi: 10.1038/s41541-021-00345-0.
6
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
7
Effect of small molecule signaling in PepFect14 transfection.小分子信号对 PepFect14 转染的影响。
PLoS One. 2020 Jan 30;15(1):e0228189. doi: 10.1371/journal.pone.0228189. eCollection 2020.
8
A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo.一种谷氨酸-尿素-赖氨酸配体共轭脂质纳米颗粒/小干扰RNA系统在体内抑制雄激素受体表达。
Mol Ther Nucleic Acids. 2016;5(8):e348. doi: 10.1038/mtna.2016.43.
9
(125)I-Labelled 2-Iodoestrone-3-sulfate: synthesis, characterization and OATP mediated transport studies in hormone dependent and independent breast cancer cells.碘-125标记的2-碘雌酮-3-硫酸盐:在激素依赖性和非依赖性乳腺癌细胞中的合成、表征及有机阴离子转运多肽介导的转运研究
Nucl Med Biol. 2015 Mar;42(3):274-82. doi: 10.1016/j.nucmedbio.2014.10.011. Epub 2014 Nov 8.
10
Lipid nanoparticles for short interfering RNA delivery.用于短干扰RNA递送的脂质纳米颗粒。
Adv Genet. 2014;88:71-110. doi: 10.1016/B978-0-12-800148-6.00004-3.